| Filed On | Filing |
|---|---|
| 03 Nov 2026 |
8-K: Results of Operations and Financial Condition
CLEVELAND, OH, November 3, 2026 – Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthc... |
| 14 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On August 11, 2026, James C. Neary notified the Board of Directors (the “Board”) of Sotera Health Company (the “Company”) of his resignation as a Class I director, effective August 13, 2026 (the “Effective Date”). Mr. Neary’s resignation... |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
CLEVELAND, OH, August 6, 2026 – Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcar... |
| 22 May 2026 |
8-K: Submission of Matters to a Vote of Security Holders
Sotera Health Company (the “Company”) held its 2026 annual meeting of stockholders on May 21, 2026 (the “Annual Meeting”). At the Annual Meeting, the stockholders (1) elected all four director nominees as Class III directors to serve a t... |
| 20 May 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
AMENDMENT NO. 7 TO FIRST LIEN CREDIT AGREEMENT, dated as of May 20, 2026 (this “Amendment”), is made and entered into by and among Sotera Health Company (f/k/a Sotera Health Topco, Inc.), a Delaware corporation (“Holdings”), SOTERA HEALT... |
| 13 May 2026 |
8-K: Termination of a Material Definitive Agreement; Other Events
Certain stockholders named in Schedule 2 hereto (the “Selling Stockholders”) of Sotera Health Company, a Delaware corporation (the “Company”), propose to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), ... |
| 05 May 2026 |
8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
CLEVELAND, OH, May 5, 2026 – Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare i... |
| 16 Mar 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On March 12, 2026, as a result of a reduction in the number of directors that certain stockholders are entitled to designate for election to the Board of Directors (the “Board”) of Sotera Health Company (the “Company”), Constantine S. Mi... |
| 06 Mar 2026 |
8-K: Other Events
Certain stockholders named in Schedule 2 hereto (the “Selling Stockholders”) of Sotera Health Company, a Delaware corporation (the “Company”), propose to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), ... |
| 24 Feb 2026 |
8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
CLEVELAND, OH, February 24, 2026 – Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the health... |
| 05 Feb 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On February 4, 2026, the Board of Directors (the “Board”) of Sotera Health Company (the “Company”) increased the size of the Board from eleven directors to twelve directors and appointed Richard G. Kyle as a Class III director of the Boa... |
| 12 Jan 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
CLEVELAND, OH, January 12, 2026 - Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthc... |
| 10 Nov 2025 |
8-K: Other Events
Certain stockholders named in Schedule 2 hereto (the “Selling Stockholders”) of Sotera Health Company, a Delaware corporation (the “Company”), propose to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), ... |
| 04 Nov 2025 |
8-K: Results of Operations and Financial Condition
CLEVELAND, OH, November 4, 2025 – Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthc... |
| 18 Sep 2025 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
AMENDMENT NO. 6 TO FIRST LIEN CREDIT AGREEMENT, dated as of September 17, 2025 (this “Amendment”), is made and entered into by and among Sotera Health Company (f/k/a Sotera Health Topco, Inc.), a Delaware corporation (“Holdings”), SOTERA... |
| 05 Sep 2025 |
8-K: Other Events
Certain stockholders named in Schedule 2 hereto (the “Selling Stockholders”) of Sotera Health Company, a Delaware corporation (the “Company”), propose to sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), ... |
| 08 Aug 2025 |
8-K: Results of Operations and Financial Condition
CLEVELAND, OH, August 8, 2025 – Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcar... |
| 24 Jul 2025 |
8-K: Regulation FD Disclosure
On July 23, 2025, Sterigenics U.S., LLC (“Sterigenics”), a subsidiary of Sotera Health Company, entered into a binding term sheet to resolve 129 ethylene oxide (“EO”) claims against Sterigenics relating to its former facility in Willowbr... |
| 23 May 2025 |
8-K: Submission of Matters to a Vote of Security Holders
Sotera Health Company (the “Company”) held its 2025 annual meeting of stockholders on May 21, 2025 (the “Annual Meeting”). At the Annual Meeting, the stockholders (1) elected all three director nominees as Class II directors to serve a t... |
| 01 May 2025 |
8-K: Results of Operations and Financial Condition
CLEVELAND, OH, May 1, 2025 – Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare i... |
Loading...